FDA.reportPublic FDA data

MESALAMINE

Substance profile for UNII 4Q81I59GXC, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MESALAMINE
Structure render from PubChem CID 4075

Substance Identity#

UNII
4Q81I59GXC
Preferred term
MESALAMINE
Registry number
89-57-6
EC number
201-919-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C7H7NO3
Chemical structure for MESALAMINE
Structure render from PubChem CID 4075

Chemical And Database Identifiers#

InChIKey
KBOPZPXVLCULAV-UHFFFAOYSA-N
SMILES
NC1=CC=C(O)C(=C1)C(O)=O
RxCUI
52582
PubChem
4075
NCIt
C29249
INN ID
5444

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4075https://pubchem.ncbi.nlm.nih.gov/compound/4075
PubChem InChIKey SearchKBOPZPXVLCULAV-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=KBOPZPXVLCULAV-UHFFFAOYSA-N
RxNorm52582https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=52582
NCI ThesaurusC29249https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29249
FDA Substance Registration System4Q81I59GXChttps://precision.fda.gov/uniisearch/srs/unii/4Q81I59GXC
European Community number201-919-1https://commonchemistry.cas.org/results?q=201-919-1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
MESALAMINEACTIVE MOIETY4Q81I59GXCAsacol ® (mesalamine) Delayed-Release Tablets2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCAsacol ® (mesalamine) Delayed-Release Tablets2
MESALAMINEACTIVE MOIETY4Q81I59GXCThese highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
MESALAMINEACTIVE INGREDIENT4Q81I59GXCThese highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
MESALAMINEACTIVE INGREDIENT4Q81I59GXC357e0e6b-cfbd-454c-82d7-cfc460dc0d681
MESALAMINEACTIVE MOIETY4Q81I59GXC357e0e6b-cfbd-454c-82d7-cfc460dc0d681
mesalamineACTIVE MOIETY4Q81I59GXCAsacol ® (mesalamine) Delayed-Release Tablets2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCAsacol ® (mesalamine) Delayed-Release Tablets2
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3702
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3702
MESALAMINEACTIVE INGREDIENT4Q81I59GXCLIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
MESALAMINEACTIVE MOIETY4Q81I59GXCLIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
MESALAMINEACTIVE MOIETY4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [SHIRE US MANUFACTURING INC.]21
MESALAMINEACTIVE INGREDIENT4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [SHIRE US MANUFACTURING INC.]21
MESALAMINEACTIVE MOIETY4Q81I59GXCAPRISO (MESALAMINE) CAPSULE, EXTENDED RELEASE [SALIX PHARMACEUTICALS, INC.]14
MESALAMINEACTIVE INGREDIENT4Q81I59GXCAPRISO (MESALAMINE) CAPSULE, EXTENDED RELEASE [SALIX PHARMACEUTICALS, INC.]14
MESALAMINEACTIVE MOIETY4Q81I59GXCDELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]10
MESALAMINEACTIVE INGREDIENT4Q81I59GXCDELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]10
MesalamineACTIVE MOIETY4Q81I59GXCCANASA (MESALAMINE) SUPPOSITORY [APTALIS PHARMA US INC]9
MesalamineACTIVE INGREDIENT4Q81I59GXCCANASA (MESALAMINE) SUPPOSITORY [APTALIS PHARMA US INC]9
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]6
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]6
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL HD (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]5
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL HD (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC]5
MESALAMINEACTIVE MOIETY4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [CARDINAL HEALTH]4
MESALAMINEACTIVE INGREDIENT4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [CARDINAL HEALTH]4
mesalamineACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH]3
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH]3
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH]3
mesalamineACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH]3
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE KIT [PERRIGO NEW YORK INC]3
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE KIT [PERRIGO NEW YORK INC]3
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET [REMEDYREPACK INC. ]2
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET [REMEDYREPACK INC. ]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]2
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCDELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
MESALAMINEACTIVE MOIETY4Q81I59GXCDELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE ENEMA [PERRIGO NEW YORK INC]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE ENEMA [PERRIGO NEW YORK INC]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE KIT [PERRIGO NEW YORK INC]2
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE KIT [PERRIGO NEW YORK INC]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE SUSPENSION [FRANKLIN PHARMACEUTICAL LLC]2
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE SUSPENSION [FRANKLIN PHARMACEUTICAL LLC]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [CARILION MATERIALS MANAGEMENT]2
MESALAMINEACTIVE MOIETY4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [CARILION MATERIALS MANAGEMENT]2
MesalamineACTIVE INGREDIENT4Q81I59GXCSF ROWASA (MESALAMINE) SUSPENSION [ALAVEN PHARMACEUTICAL LLC]2
MesalamineACTIVE MOIETY4Q81I59GXCSF ROWASA (MESALAMINE) SUSPENSION [ALAVEN PHARMACEUTICAL LLC]2
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]1
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE MOIETY4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE MOIETY4Q81I59GXCLIALDA (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCLIALDA (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]1
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE CAPSULE [PRASCO LABORATORIES]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE CAPSULE [PRASCO LABORATORIES]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCMESALAMINE ENEMA [GAVIS PHARMACEUTICALS, LLC]1
MESALAMINEACTIVE MOIETY4Q81I59GXCMESALAMINE ENEMA [GAVIS PHARMACEUTICALS, LLC]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE MOIETY4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE MOIETY4Q81I59GXCPENTASA (MESALAMINE) CAPSULE [REMEDYREPACK INC. ]1
MESALAMINEACTIVE INGREDIENT4Q81I59GXCROWASA (MESALAMINE) ENEMA [ALAVEN PHARMACEUTICAL LLC]1
MESALAMINEACTIVE MOIETY4Q81I59GXCROWASA (MESALAMINE) ENEMA [ALAVEN PHARMACEUTICAL LLC]1